Cargando…

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies

Mouse models are the most commonly used in vivo system for biomedical research, in which immune-related diseases and therapies can be investigated in syngeneic and immunologically intact hosts. However, because there are significant differences between rodent and human, most findings from convention...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Liguang, Jin, Chun-Hui, Tan, Shulian, Liu, Wentao, Yang, Yong-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578411/
https://www.ncbi.nlm.nih.gov/pubmed/33133105
http://dx.doi.org/10.3389/fimmu.2020.591669
_version_ 1783598358938517504
author Sun, Liguang
Jin, Chun-Hui
Tan, Shulian
Liu, Wentao
Yang, Yong-Guang
author_facet Sun, Liguang
Jin, Chun-Hui
Tan, Shulian
Liu, Wentao
Yang, Yong-Guang
author_sort Sun, Liguang
collection PubMed
description Mouse models are the most commonly used in vivo system for biomedical research, in which immune-related diseases and therapies can be investigated in syngeneic and immunologically intact hosts. However, because there are significant differences between rodent and human, most findings from conventional mouse models cannot be applied to humans. The humanized mouse with a functional human immune system, also referred to as human immune system (HIS) mouse, is the only model available to date for in vivo studies in real-time of human immune function under physiological and pathological conditions. HIS mice with human tumor xenografts are considered an emerging and promising in vivo model for modeling human cancer immunotherapy. In this review, we briefly discuss the protocols to construct HIS mice and elaborate their pros and cons. Particular attention is given to HIS mouse models with human tumor that is autologous or genetically identical to the human immune system, which are discussed with examples of their usefulness in modeling human cancer immunotherapies.
format Online
Article
Text
id pubmed-7578411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75784112020-10-30 Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies Sun, Liguang Jin, Chun-Hui Tan, Shulian Liu, Wentao Yang, Yong-Guang Front Immunol Immunology Mouse models are the most commonly used in vivo system for biomedical research, in which immune-related diseases and therapies can be investigated in syngeneic and immunologically intact hosts. However, because there are significant differences between rodent and human, most findings from conventional mouse models cannot be applied to humans. The humanized mouse with a functional human immune system, also referred to as human immune system (HIS) mouse, is the only model available to date for in vivo studies in real-time of human immune function under physiological and pathological conditions. HIS mice with human tumor xenografts are considered an emerging and promising in vivo model for modeling human cancer immunotherapy. In this review, we briefly discuss the protocols to construct HIS mice and elaborate their pros and cons. Particular attention is given to HIS mouse models with human tumor that is autologous or genetically identical to the human immune system, which are discussed with examples of their usefulness in modeling human cancer immunotherapies. Frontiers Media S.A. 2020-10-08 /pmc/articles/PMC7578411/ /pubmed/33133105 http://dx.doi.org/10.3389/fimmu.2020.591669 Text en Copyright © 2020 Sun, Jin, Tan, Liu and Yang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sun, Liguang
Jin, Chun-Hui
Tan, Shulian
Liu, Wentao
Yang, Yong-Guang
Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
title Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
title_full Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
title_fullStr Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
title_full_unstemmed Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
title_short Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
title_sort human immune system mice with autologous tumor for modeling cancer immunotherapies
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578411/
https://www.ncbi.nlm.nih.gov/pubmed/33133105
http://dx.doi.org/10.3389/fimmu.2020.591669
work_keys_str_mv AT sunliguang humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies
AT jinchunhui humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies
AT tanshulian humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies
AT liuwentao humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies
AT yangyongguang humanimmunesystemmicewithautologoustumorformodelingcancerimmunotherapies